Molly Henderson

Molly Henderson

Chief Financial and Business OfficeratPhathom Pharmaceuticals· In proxies 2022–2024

Pay in FY2024-24% from the year before · Phathom Pharmaceuticals stock -11.1% the same year

Molly Henderson was paid $1.4M in FY2024 (Dec), down 24%. Phathom Pharmaceuticals stock fell 11.1% that year.

Pay$100 in the stock at the end of FY21 → $41
Pay is from the Summary Compensation Table of each Phathom Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Phathom PharmaceuticalsPublic company · 4 yr
    • Chief Financial and Business Officer2022 – Present · 4 yrStock in role -69%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?